Click to copy
Click to copy

BioCryst: 2Q Earnings Snapshot

August 6, 2019

DURHAM, N.C. (AP) _ BioCryst Pharmaceuticals Inc. (BCRX) on Tuesday reported a loss of $37.6 million in its second quarter.

The Durham, North Carolina-based company said it had a loss of 34 cents per share.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.

The drugmaker posted revenue of $1.4 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $2.5 million.

The company’s shares closed at $2.84. A year ago, they were trading at $5.80.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BCRX at https://www.zacks.com/ap/BCRX

All contents © copyright 2019 The Associated Press. All rights reserved.